Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model

Thomas Ertveldt
, Lien De Beck
, Kirsten De Ridder
, Hanne Locy
, Wout De Mey
, Cleo Goyvaerts
, Quentin Lecocq
, Hannelore Ceuppens
, Yannick De Vlaeminck
, Robin Maximilian Awad
, Marleen Keyaerts
, Nick Devoogdt
, Matthias D'Huyvetter
, Karine Breckpot
, Ahmet Krasniqi

Onderzoeksoutput: Article › peer review

19 Citaten (Scopus)

143 Downloads (Pure)

2 resultaten
- Titel
- Begindatum(oplopend)

DataSet-Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Ertveldt, T. (Creator), De Beck, L. (Creator), De Ridder, K. (Creator), Locy, H. (Creator), de Mey, W. (Creator), Goyvaerts, C. (Creator), Lecocq, Q. (Creator), Ceuppens, H. (Creator), De Vlaeminck, Y. (Creator), Awad, R. M. (Creator), Keyaerts, M. (Creator), Devoogdt, N. (Creator), D'Huyvetter, M. (Creator), Breckpot, K. (Creator) & Krasniqi, A. (Creator), Zenodo, 16 dec. 2024
DOI: 10.5281/zenodo.14499732
Dataset
B16-huCD20 tumors treated with 177Lu-TRT were subjected to multiplex analysis to study the tumor immune signature.
Ertveldt, T. (Creator), De Ridder, K. (Creator), Locy, H. (Creator) & Breckpot, K. (Creator), Gene Expression Omnibus (GEO), 2 apr. 2022
Dataset